Key facts
- It has raised $104.5M; the latest was Early Stage VC ($45.0M) in Dec 2025.
- Notable investors include Qiming Venture Partners, Sinovation Ventures, Granite Asia, LYFE Capital, Megarobo.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ChemLex
- ·The full record, as it builds
Funding rounds
No funding rounds for ChemLex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ChemLex
Provider of automated intelligent services for chemical synthesis intended for manufacturers in electronics, automotive, energy, and specialty industries. The company focuses on closed-loop collaborative research and development through artificial intelligence, chemical synthesis path planning, and high-throughput, fully automated laboratory technology platforms, enabling clients to shorten the delivery cycle of the chemical synthesis link in the new drug development cycle.
- Sector
- Information Technology
- HQ
- Shanghai, China
- Founded
- 2022
- Website
- chemlex.com/
- Ownership
- Privately Held (backing)
ChemLex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ChemLex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ChemLex in its N-PORT filings yet. We sweep new filings monthly.